Early intervention with biologic therapy in Crohn′s disease: how early is early?JOURNAL OF CROHNS & COLITISIF8.72023-05-236PRE
The Landscape of Tumor-Infiltrating Immune Cells in Feline Mammary Carcinoma: Pathological and Clinical Implications猫乳腺癌中肿瘤浸润免疫细胞的景观: 病理和临床意义CELLSIF5.22022-08-1812OAAI
Mental Health, Work Presenteeism, and Exercise in Inflammatory Bowel DiseaseJOURNAL OF CROHNS & COLITISIF8.72022-03-0319PRE
Tumor microenvironment of human breast cancer, and feline mammary carcinoma as a potential study model人乳腺癌的肿瘤微环境,以及作为潜在研究模型的猫乳腺癌BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCERIF8.32021-08-0144OAAI
Bowel ultrasound as an early monitoring tool to assess disease activity in Crohn's disease patients after induction therapy with infliximabJOURNAL OF CROHNS & COLITISIF8.72021-05-270OA
Outcomes of multiswitching from original infliximab to biosimilars in patients with inflammatory bowel diseaseJOURNAL OF CROHNS & COLITISIF8.72021-05-271PRE
Early therapeutic drug monitoring after induction therapy with infliximab: correlation with intestinal ultrasoundJOURNAL OF CROHNS & COLITISIF8.72021-05-270PRE
Tyrosine Kinase Inhibitors Are Promising Therapeutic Tools for Cats with HER2-Positive Mammary CarcinomaPHARMACEUTICSIF5.52021-03-0611OAAI
Clinical Relevance of the serum CTLA-4 in Cats with Mammary CarcinomaSCIENTIFIC REPORTSIF3.92020-03-0225OAAI
Rituximab Use in Pediatric Autoimmune Diseases Four Case ReportsCONTEMPORARY CHALLENGES IN AUTOIMMUNITYIF02009-09-0113OAAI